AUS
NZ
UK
CA
USA
IND
Highlights
FTSE 100 Index rises despite global trade uncertainty
Mining stocks lift as silver prices hit long-term high
Healthcare and consulting stocks support broader gains
The FTSE 100 Index today advanced despite heightened global trade tensions and a weakening British pound, as key sectors saw gains and notable company updates lifted investor sentiment.
The blue-chip index moved upward, contrasting with declines in other European benchmarks following remarks from the U.S. administration regarding potential tariff hikes on imports from the EU and Mexico. While global uncertainty loomed, several U.K.-listed companies in the FTSE 100 and beyond reported updates that provided tailwinds for the market.
Silver Surge Boosts Mining Sector
Silver prices touched their highest level since 2011 during early trading, helping bolster sentiment around precious metal-linked equities. Mining companies Fresnillo (LON:FRES) and Hochschild Mining (LON:HOCM) were among the early beneficiaries of this trend. Fresnillo, a member of the FTSE 100, initially rallied in response to silver's strength as investors gravitated toward safe-haven assets amid growing economic uncertainty.
Although silver later retraced from its session highs, the early surge was sufficient to lift related stocks and support the wider materials sector in London.
Asset Management Sees Growth in AUM
Ashmore Group (LON:ASHM) reported a quarterly rise in assets under management, led by strong investment performance across both fixed income and equity categories. The increase in AUM reflects improving conditions in emerging markets and a gradual stabilisation in global investor flows. While fixed income strategies remained broadly unchanged, equity inflows saw positive momentum, reinforcing the group’s position in multi-asset management.
Healthcare Sector Gains on Trial Results
AstraZeneca (LON:AZN) saw gains following the release of promising results from a late-stage trial of its experimental blood pressure therapy, baxdrostat. The treatment demonstrated meaningful improvements for patients with treatment-resistant hypertension, achieving its primary goals in the trial. These results added strength to the company’s broader cardiovascular portfolio and contributed to positive sentiment in the pharmaceutical segment.
Consultancy Firm Reports Strong Revenue Growth
Elixirr International (LON:ELIX) also posted a strong performance, with first-half revenue showing solid year-over-year growth. The company’s update reaffirmed confidence in meeting full-year targets. Positive results from mid-cap consultancy firms like Elixirr provide a helpful backdrop for understanding resilience across the professional services sector.
M&A Activity Reshapes IT Landscape
Distribution group DCC (LON:DCC) announced the sale of its IT services division to an investment firm, continuing its portfolio reshaping strategy. This strategic move is aligned with DCC’s focus on streamlining operations and concentrating on core sectors.
Pharmaceutical Update on Vaccine Review
GSK (LON:GSK) stated that U.S. regulators have accepted a filing to expand the use of its Arexvy vaccine. This update reflects ongoing progress in the company’s respiratory portfolio and continued emphasis on vaccine innovation.
Recruitment Market Cools Further
New U.K. employment data pointed to a continued slowdown in hiring, with permanent placements declining sharply. The retail sector showed particular weakness, accompanied by easing wage growth and an increase in available candidates. The data suggests that companies remain cautious in the current environment, even as some sectors continue to expand.
